These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 11984800)
21. Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications. van Gaal JC; Flucke UE; Roeffen MH; de Bont ES; Sleijfer S; Mavinkurve-Groothuis AM; Suurmeijer AJ; van der Graaf WT; Versleijen-Jonkers YM J Clin Oncol; 2012 Jan; 30(3):308-15. PubMed ID: 22184391 [TBL] [Abstract][Full Text] [Related]
22. [Evidence of genetic alterations in chromosome 11 in embryonal and alveolar rhabdomyosarcoma]. Brinkschmidt C; Poremba C; Schäfer KL; Simon R; Jürgens H; Böcker W; Dockhorn-Dworniczak B Verh Dtsch Ges Pathol; 1998; 82():210-4. PubMed ID: 10095436 [TBL] [Abstract][Full Text] [Related]
23. A comparative study on morphology and immunohistochemistry of rhabdomyosarcoma and embryonal skeletal muscles. Lai R; Tian Y; An J; Zhou MW; Zou G; Li W Chin Med J (Engl); 1997 May; 110(5):392-6. PubMed ID: 9594310 [TBL] [Abstract][Full Text] [Related]
24. Sarcoma of the prostate: a single institutional review. Janet NL; May AW; Akins RS Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120 [TBL] [Abstract][Full Text] [Related]
25. Rhabdomyosarcoma. Morphologic, immunohistochemical, and DNA study. Gruchała A; Niezabitowski A; Wasilewska A; Sikora K; Ryś J; Szklarski W; Jaszcz A; Lackowska B; Herman K Gen Diagn Pathol; 1997 Feb; 142(3-4):175-84. PubMed ID: 9065581 [TBL] [Abstract][Full Text] [Related]
26. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy. Cheng L; Sebo TJ; Cheville JC; Pisansky TM; Slezak J; Bergstralh EJ; Pacelli A; Neumann RM; Zincke H; Bostwick DG Cancer; 1999 Mar; 85(6):1293-9. PubMed ID: 10189134 [TBL] [Abstract][Full Text] [Related]
28. Treatment strategies for perianal rhabdomyosarcoma: report of two cases. Watanabe Y; Yamaguchi A; Isogai M; Kaneoka Y; Suzuki M; Ando H; Horibe K Surg Today; 2004; 34(8):719-24. PubMed ID: 15290407 [TBL] [Abstract][Full Text] [Related]
29. Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study. Zin A; Bertorelle R; Dall'Igna P; Manzitti C; Gambini C; Bisogno G; Rosolen A; Alaggio R Am J Surg Pathol; 2014 Feb; 38(2):273-8. PubMed ID: 24418861 [TBL] [Abstract][Full Text] [Related]
30. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550 [TBL] [Abstract][Full Text] [Related]
31. Ki-S1--a prognostic marker for hypopharyngeal carcinoma with potential predictive value for response to chemotherapy. Kuropkat C; Rudolph P; Parwaresch R; Werner JA Anticancer Res; 2003; 23(5A):3965-70. PubMed ID: 14666704 [TBL] [Abstract][Full Text] [Related]
32. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases]. Yu L; Wang J Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377 [TBL] [Abstract][Full Text] [Related]
33. Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma. Oda Y; Kohashi K; Yamamoto H; Tamiya S; Kohno K; Kuwano M; Iwamoto Y; Tajiri T; Taguchi T; Tsuneyoshi M Cancer Sci; 2008 Apr; 99(4):726-32. PubMed ID: 18377424 [TBL] [Abstract][Full Text] [Related]
34. Pattern of presentation and outcome of ophthalmic rhabdomyosarcoma in Ibadan. Fasina O Afr J Med Med Sci; 2013 Jun; 42(2):165-9. PubMed ID: 24377202 [TBL] [Abstract][Full Text] [Related]
35. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers. Sartori F; Alaggio R; Zanazzo G; Garaventa A; Di Cataldo A; Carli M; Rosolen A; Cancer; 2006 Apr; 106(8):1766-75. PubMed ID: 16544315 [TBL] [Abstract][Full Text] [Related]
36. Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study. Lee JS; Lim SM; Rha SY; Roh JK; Cho YJ; Shin KH; Yang WI; Kim SH; Kim HS J Clin Pathol; 2014 Jan; 67(1):33-9. PubMed ID: 23922356 [TBL] [Abstract][Full Text] [Related]
37. Rhabdomyosarcoma in children - current pathologic and molecular classification. Dziuba I; Kurzawa P; Dopierała M; Larque AB; Januszkiewicz-Lewandowska D Pol J Pathol; 2018; 69(1):20-32. PubMed ID: 29895123 [TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and the prognosis of childhood rhabdomyosarcoma in 60 patients treated at a single institute. Company F; Pedram M; Rezaei N Acta Med Iran; 2011; 49(4):219-24. PubMed ID: 21713731 [TBL] [Abstract][Full Text] [Related]
39. Rhabdomyosarcoma of the urinary bladder and vagina: a clinicopathologic study with emphasis on recurrent disease: a report from the Kiel Pediatric Tumor Registry and the German CWS Study. Leuschner I; Harms D; Mattke A; Koscielniak E; Treuner J Am J Surg Pathol; 2001 Jul; 25(7):856-64. PubMed ID: 11420456 [TBL] [Abstract][Full Text] [Related]
40. Beta-catenin mutation does not seem to have an effect on the tumorigenesis of pediatric rhabdomyosarcomas. Bouron-Dal Soglio D; Rougemont AL; Absi R; Giroux LM; Sanchez R; Barrette S; Fournet JC Pediatr Dev Pathol; 2009; 12(5):371-3. PubMed ID: 19222307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]